Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

Phase 4

2(33.3%)

N/A

2(33.3%)

Phase 2

2(33.3%)

6Total

Phase 4(2)

N/A(2)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT05564130Phase 4Active Not Recruiting

Bicarbonate for In-Hospital Cardiac Arrest

Role: lead

NCT06047119Not ApplicableCompleted

Respiratory and Hemodynamic Targets During General Anesthesia

Role: lead

NCT06781892Not ApplicableRecruiting

Strategies for Defibrillation During Out-of-Hospital Cardiac Arrest

Role: lead

NCT05205031Phase 4Active Not Recruiting

Intravenous Vs. Intraosseous Vascular Access During Out-of-Hospital

Role: lead

NCT04153435Phase 2Completed

Calcium for Out-of-Hospital Cardiac Arrest

Role: lead

NCT03640949Phase 2Completed

Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest

Role: lead

All 6 trials loaded